These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 32542935
1. Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma. Saba KH, Cornmark L, Hofvander J, Magnusson L, Nilsson J, van den Bos H, Spierings DC, Foijer F, Staaf J, Brosjö O, Sumathi VP, Lam SW, Szuhai K, Bovée JV, Kovac M, Baumhoer D, Styring E, Nord KH. J Pathol Clin Res; 2020 Oct; 6(4):231-237. PubMed ID: 32542935 [Abstract] [Full Text] [Related]
2. Recurrent rearrangements of FOS and FOSB define osteoblastoma. Fittall MW, Mifsud W, Pillay N, Ye H, Strobl AC, Verfaillie A, Demeulemeester J, Zhang L, Berisha F, Tarabichi M, Young MD, Miranda E, Tarpey PS, Tirabosco R, Amary F, Grigoriadis AE, Stratton MR, Van Loo P, Antonescu CR, Campbell PJ, Flanagan AM, Behjati S. Nat Commun; 2018 Jun 01; 9(1):2150. PubMed ID: 29858576 [Abstract] [Full Text] [Related]
6. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma. Lam SW, Cleven AHG, Kroon HM, Briaire-de Bruijn IH, Szuhai K, Bovée JVMG. Virchows Arch; 2020 Mar 01; 476(3):455-463. PubMed ID: 31768625 [Abstract] [Full Text] [Related]
7. Clinicopathologic study of 6 cases of epithelioid osteoblastoma of the jaws with immunoexpression analysis of FOS and FOSB. Pereira TDSF, Andrade BAB, Romañach MJ, Pereira NB, Gomes CC, Mariz BALA, Almeida OP, Agostini M, van Heerden WFP, Carlos R, Gomez RS, Fonseca FP. Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug 01; 130(2):191-199. PubMed ID: 32482537 [Abstract] [Full Text] [Related]
11. Methylation and copy number profiling: emerging tools to differentiate osteoblastoma from malignant mimics? Ameline B, Nathrath M, Nord KH, de Flon FH, Bovée JVMG, Krieg AH, Höller S, Hench J, Baumhoer D. Mod Pathol; 2022 Sep 01; 35(9):1204-1211. PubMed ID: 35347251 [Abstract] [Full Text] [Related]
12. FOS-ANKH and FOS-RUNX2 Fusion Genes in Osteoblastoma. Panagopoulos I, Gorunova L, Lobmaier I, Andersen K, Kostolomov I, Lund-Iversen M, Bjerkehagen B, Heim S. Cancer Genomics Proteomics; 2020 Sep 01; 17(2):161-168. PubMed ID: 32108038 [Abstract] [Full Text] [Related]
15. What's new in bone forming tumours of the skeleton? Franceschini N, Lam SW, Cleton-Jansen AM, Bovée JVMG. Virchows Arch; 2020 Jan 01; 476(1):147-157. PubMed ID: 31741049 [Abstract] [Full Text] [Related]
17. Epithelioid multinodular osteoblastoma: a clinicopathologic analysis of 26 cases. Zon Filippi R, Swee RG, Krishnan Unni K. Am J Surg Pathol; 2007 Aug 01; 31(8):1265-8. PubMed ID: 17667552 [Abstract] [Full Text] [Related]
18. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma. Erdogan KE, Pacheco M, Gambarotti M, Magagnoli G, Sbaraglia M, Frisoni T, Righi A, Dei Tos AP. Virchows Arch; 2021 Sep 01; 479(3):529-535. PubMed ID: 33511430 [Abstract] [Full Text] [Related]